Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 94

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

FBXW7α attenuates inflammatory signalling by downregulating C/EBPδ and its target gene Tlr4

Balamurugan, Kuppusamy, Sharan, Shikha, Klarmann, Kimberly D., Zhang, Youhong, Coppola, Vincenzo, Summers, Glenn H., Roger, Thierry, Morrison, Deborah K., Keller, Jonathan R., Sterneck, Esta · 2013 · Nature Communications

Abstract

Toll-like receptor 4 (Tlr4) has a pivotal role in innate immune responses, and the transcription factor CCAAT/enhancer binding protein delta (C/EBPδ, Cebpd) is a Tlr4-induced gene. Here we identify a positive feedback loop in which C/EBPδ activates Tlr4 gene expression in macrophages and tumour cells. In addition, we discovered a negative feedback loop whereby the tumour suppressor FBXW7α (FBW7, Cdc4), whose gene expression is inhibited by C/EBPδ, targets C/EBPδ for degradation when C/EBPδ is phosphorylated by GSK-3β. Consequently, FBXW7α suppresses Tlr4 expression and responses to the ligand lipopolysaccharide. FBXW7α depletion alone is sufficient to augment pro-inflammatory signalling in vivo. Moreover, as inflammatory pathways are known to modulate tumour biology, Cebpd null mammary tumours, which have reduced metastatic potential, show altered expression of inflammation-associated genes. Together, these findings reveal a role for C/EBPδ upstream of Tlr4 signalling and uncover a function for FBXW7α as an attenuator of inflammatory signalling. The innate immune sensor Toll-like receptor 4 controls inflammatory gene expression. Here the authors identify a network of positive and negative feedback loops involving the transcription factor C/EBPd and ubiquitin ligase substrate adaptor FBXW7a that regulate TLR4 levels and inflammatory signalling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms2677

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Research works printed but not linked: 46

  1. Roger, T. et al. Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc. Natl Acad. Sci. USA 106, 2348–2352 (2009) . · DOI · Paper page
  2. Lin, Q., Li, M., Fang, D., Fang, J. & Su, S. B. . The essential roles of Toll-like receptor signaling pathways in sterile inflammatory diseases. Int. Immunopharmacol. 11, 1422–1432 (2011) . · DOI
  3. Huang, B. et al. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65, 5009–5014 (2005) . · DOI · Paper page
  4. Szczepanski, M. J. et al. Triggering of Toll-like receptor 4 expressed on human head and neck squamous cell carcinoma promotes tumor development and protects the tumor from immune attack. Cancer Res. 69, 3105–3113 (2009) . · DOI · Paper page
  5. Liao, S. J. et al. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes alphavbeta3-mediated adhesion and invasive migration. Breast Cancer Res Treat. 133, 853–863 (2012) . · DOI
  6. Yang, H. et al. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion. J. Exp. Clin. Cancer Res. 29, 92 (2010) . · DOI · Paper page
  7. Zhao, Y. et al. Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 6, e29363 (2011) . · DOI
  8. Ramji, D. P. & Foka, P. . CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem. J. 365, 561–575 (2002) . · DOI · Paper page
  9. Slofstra, S. H. et al. Gene expression profiling identifies C/EBPdelta as a candidate regulator of endotoxin-induced disseminated intravascular coagulation. Am. J. Respir. Crit. Care Med. 176, 602–609 (2007) . · DOI
  10. Tsai, V. W. W. et al. Ccaat/enhancer binding protein-delta expression by dendritic cells regulates CNS autoinflammatory disease. J. Neurosci. 31, 17612–17621 (2011) . · DOI
  11. Balamurugan, K. et al. The tumour suppressor C/EBPdelta inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J. 29, 4106–4117 (2010) . · DOI
  12. Cheng, Y. & Li, G. . Role of the ubiquitin ligase Fbw7 in cancer progression. Cancer Metastasis Rev. 31, 75–87 (2012) . · DOI
  13. Semenza, G. L. . HIF-1: upstream and downstream of cancer metabolism. Curr. Opin. Genet. Dev. 20, 51–56 (2010) . · DOI · Paper page
  14. Lu, X. & Kang, Y. . Hypoxia and hypoxia-inducible factors: master regulators of metastasis. Clin. Cancer Res. 16, 5928–5935 (2010) . · DOI · Paper page
  15. Guy, C. T. et al. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc. Natl Acad. Sci. USA 89, 10578–10582 (1992) . · DOI · Paper page
  16. Pawar, S. A. et al. C/EBPdelta targets cyclin D1 for proteasome-mediated degradation via induction of CDC27/APC3 expression. Proc. Natl Acad. Sci. USA 107, 9210–9215 (2010) . · DOI
  17. Sarkar, T. R. et al. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPdelta expression and contributes to transformation of breast tumor cells. Mol. Cell Biol. 32, 320–332 (2012) . · DOI
  18. Cramer, T. et al. HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112, 645–657 (2003) . · DOI · Paper page
  19. Outtz, H. H., Wu, J. K., Wang, X. & Kitajewski, J. . Notch1 deficiency results in decreased inflammation during wound healing and regulates vascular endothelial growth factor receptor-1 and inflammatory cytokine expression in macrophages. J. Immunol. 185, 4363–4373 (2010) . · DOI
  20. Mao, J. H. et al. FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321, 1499–1502 (2008) . · DOI · Paper page
  21. Martin, M., Rehani, K., Jope, R. S. & Michalek, S. M. . Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nat. Immunol. 6, 777–784 (2005) . · DOI · Paper page
  22. Wang, H. et al. IFN-beta production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-beta. J. Immunol. 181, 6797–6802 (2008) . · DOI
  23. Marques, J. T. & Williams, B. R. . Activation of the mammalian immune system by siRNAs. Nat. Biotechnol. 23, 1399–1405 (2005) . · DOI · Paper page
  24. Roger, T., David, J., Glauser, M. P. & Calandra, T. . MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414, 920–924 (2001) . · DOI · Paper page
  25. Won, J. S., Im, Y. B., Key, L., Singh, I. & Singh, A. K. . The involvement of glucose metabolism in the regulation of inducible nitric oxide synthase gene expression in glial cells: possible role of glucose-6-phosphate dehydrogenase and CCAAT/enhancing binding protein. J. Neurosci. 23, 7470–7478 (2003) . · DOI
  26. Zhang, Z. & Schluesener, H. J. . Mammalian toll-like receptors: from endogenous ligands to tissue regeneration. Cell. Mol. Life Sci.. 63, 2901–2907 (2006) . · DOI
  27. Grivennikov, S. I., Greten, F. R. & Karin, M. . Immunity, inflammation, and cancer. Cell 140, 883–899 (2010) . · DOI · Paper page
  28. Karnoub, A. E. & Weinberg, R. A. . Chemokine networks and breast cancer metastasis. Breast Dis. 26, 75–85 (2006) . · DOI
  29. Gonzalez-Martin, A., Gomez, L., Lustgarten, J., Mira, E. & Manes, S. . Maximal T cell-mediated antitumor responses rely upon CCR5 expression in both CD4(+) and CD8(+) T cells. Cancer Res. 71, 5455–5466 (2011) . · DOI
  30. Goswami, S. et al. Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res. 65, 5278–5283 (2005) . · DOI · Paper page
  31. Yan, C., Zhu, M., Staiger, J., Johnson, P. F. & Gao, H. . C5a-regulated CCAAT/enhancer binding protein beta and -delta are essential in Fcgamma receptor- mediated inflammatory cytokine and chemokine production in macrophages. J. Biol. Chem. 287, 3217–3230 (2012) . · DOI
  32. Zannetti, C. et al. C/EBP{delta} and STAT-1 are required for TLR8 transcriptional activity. J. Biol. Chem. 285, 34773–34780 (2010) . · DOI
  33. Kravchenko, V. V., Mathison, J. C., Schwamborn, K., Mercurio, F. & Ulevitch, R. J. . IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278, 26612–26619 (2003) . · DOI
  34. Lu, Y. C. et al. Differential role for c-Rel and C/EBPbeta/delta in TLR-mediated induction of proinflammatory cytokines. J. Immunol. 182, 7212–7221 (2009) . · DOI
  35. Maitra, U., Gan, L., Chang, S. & Li, L. . Low-Dose Endotoxin Induces Inflammation by Selectively Removing Nuclear Receptors and Activating CCAAT/Enhancer-Binding Protein {delta}. J. Immunol. 186, 4467–4473 (2011) . · DOI
  36. Min, Y. et al. C/EBP-delta regulates VEGF-C autocrine signaling in lymphangiogenesis and metastasis of lung cancer through HIF-1alpha. Oncogene 30, 4901–4909 (2011) . · DOI
  37. Imtiyaz, H. Z. & Simon, M. C. . Hypoxia-inducible factors as essential regulators of inflammation. Curr. Top Microbiol. Immunol. 345, 105–120 (2010) .
  38. Gonzalez-Reyes, S. et al. Study of TLR3, TLR4 and TLR9 in breast carcinomas and their association with metastasis. BMC Cancer 10, 665 (2010) . · DOI · Paper page
  39. Ahmed, A., Wang, J. H. & Redmond, H. P. . Silencing of TLR4 Increases Tumor Progression and Lung Metastasis in a Murine Model of Breast Cancer. Ann. Surg. Oncol e-pub ahead of print (2012) . · DOI
  40. Etokebe, G. E. et al. Single-nucleotide polymorphisms in genes encoding toll-like receptor -2, -3, -4, and -9 in case-control study with breast cancer. Genet. Test Mol. Biomarkers 13, 729–734 (2009) . · DOI
  41. Apetoh, L., Tesniere, A., Ghiringhelli, F., Kroemer, G. & Zitvogel, L. . Molecular interactions between dying tumor cells and the innate immune system determine the efficacy of conventional anticancer therapies. Cancer Res. 68, 4026–4030 (2008) . · DOI · Paper page
  42. Sterneck, E. et al. Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding protein delta. Proc. Natl Acad. Sci. USA 95, 10908–10913 (1998) . · DOI
  43. Hoover, D. L. & Nacy, C. A. . Macrophage activation to kill Leishmania tropica: defective intracellular killing of amastigotes by macrophages elicited with sterile inflammatory agents. J. Immunol. 132, 1487–1493 (1984) . · DOI
  44. van Drogen, F. et al. Ubiquitylation of cyclin E requires the sequential function of SCF complexes containing distinct hCdc4 isoforms. Mol. Cell 23, 37–48 (2006) . · DOI
  45. Morrison, D. K., Heidecker, G., Rapp, U. R. & Copeland, T. D. . Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268, 17309–17316 (1993) . · DOI · Paper page
  46. Roger, T. et al. Critical role for Ets, AP-1 and GATA-like transcription factors in regulating mouse Toll-like receptor 4 (Tlr4) gene expression. Biochem. J. 387, 355–365 (2005) . · DOI

Cited by

Metadata

Authors
Balamurugan, K., Sharan, S., Klarmann, K. D., Zhang, Y., Coppola, V., Summers, G. H., Roger, T., Morrison, D. K., Keller, J. R., & Sterneck, E.
Venue
Nature Communications
Published
2013-04-09
Volume
4
Issue
1
ISSN
2041-1723
Cited by
94
References
7
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.